According to the latest report by IMARC Group, that the global cell-based assay market size reached US$ 18.9 Billion in 2021. Cell-based assay or cellular assay is an analytical method to determine the concentration of a substance by observing its effects on living organisms (in vivo) or tissues (in vitro). It provides a closer representation of the real-life model, which helps to verify the biological activity of drugs and determine whether the antibodies produced by the patient are neutralizing the drug.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Cell-Based
Assay Market
Research
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Cell-Based Assay Market Outlook 2022-2027:
The latest report by IMARC Group, titled “Cell-Based Assay Market: Global Industry Trends, Share,
Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the global cell-based assay market
size reached US$ 18.9 Billion in 2021.
Cell-based assay or cellular assay is an analytical method to determine the concentration of a
substance by observing its effects on living organisms (in vivo) or tissues (in vitro). It provides a closer
representation of the real-life model, which helps to verify the biological activity of drugs and
determine whether the antibodies produced by the patient are neutralizing the drug.
Owing to these properties, cell-based assays are widely adopted in biomedical research and drug-
discovery screening for gene activation, cell signaling, cell proliferation, antibody-dependent cellular
cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis, and necrosis.
Request for a PDF sample of this report: https://www.imarcgroup.com/cell-based-assays-
market/requestsample

4. Report Description
Report Description and Highlights
Global Cell-Based Assay Market Drivers/Constraints:
The market is primarily driven by the growing prevalence of chronic disorders such as cancer, diabetes,
and cardiovascular diseases. Nowadays, cell-based assays are widely used for screening mutagenesis in
chronic myeloid leukemia. In addition, the rising adoption of cell-based assays in drug discovery
represents another major growth-inducing factor.
Besides this, with various technological advancements, researchers are using this technique for high
throughput screening methods like toxicity studies, drug screening, and in vitro testing. This, coupled
with extensive research and development (R&D) activities conducted by the leading players to
formulate safer drugs, is propelling the market growth.
Moreover, the introduction of 3D and label-free cell-based assays, the rising number of drug discovery
companies, and huge investments in cell-based research activities are some of the other factors creating
a favorable market outlook across the globe.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/cell-based-assays-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Product and Services:
• Consumables
• Reagents and Media
• Cells and Cell Lines
• Probes and Labels
• Instruments
• Microplates
• Microplate Readers
• High Throughput Screening
• Liquid Handling Systems
• Services
• Software

6. Report Description
Report Description and Highlights
Breakup by Technology:
• Automated Handling
• Flow Cytometry
• Label-Free Detection
• High-Throughput Screening
Breakup by Application:
• Drug Discovery
• Basic Research
• ADME Studies
• Predictive Toxicology
Breakup by End-User:
• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutions
• Contract Research Organizations

7. Report Description
Report Description and Highlights
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Looking forward, IMARC Group expects the market to reach US$ 31.4 Billion by 2027, exhibiting at a
CAGR of 8.78% during 2022-2027.

8. Report Description
Report Description and Highlights
Competitive Landscape:
• Becton Dickinson and Company
• GE Healthcare Biopharma (Danaher Corporation)
• Thermo Fisher Scientific Inc
• Merck Group
• Perkinelmer Inc
• Charles River Laboratories Inc
• Lonza Group Ltd
• Cell Signaling Technology Inc
• Promega Corporation
• Cell Biolabs Inc
• Eurofins DiscoverX Corporation
• Bio-Rad Laboratories Inc
• Corning Inc
• F. Hoffmann-La Roche AG (Roche Holding AG)
Note: We are updating our reports, If you want the report with the latest primary and secondary
data (2022-2027) including industry trends, market size and Competitive landscape, etc.
Click here: https://www.imarcgroup.com/cell-based-assays-market/requestsample

9. Report Description
Key Questions Answered in the Report
1. What has been the historical growth rate of the global Cell-Based Assay Market?
2. What has been the impact of COVID-19 on the global Cell-Based Assay Market?
3. What are the key factors driving the global Cell-Based Assay Market?
4. What is the breakup of the global Cell-Based Assay Market based on the type?
5. What is the breakup of the global Cell-Based Assay Market based on the application?
6. What is the breakup of the global Cell-Based Assay Market based on the distribution channel?
7. What are the key regions in the global Cell-Based Assay Market?
8. Who are the key players/companies in the global Cell-Based Assay Market?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends

11. Report Description Table of Contents
5 Global Cell-Based Assay Market Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product and Services
5.5 Market Breakup by Technology
5.6 Market Breakup by Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/cell-based-assays-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us